Villetes, Ricardo .

HRN: 23-52-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/12/2023
08/18/2023
IVT
500mg
Q8
T/C Tetanus Infection
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: